HRTX Historical PE Ratio image   This HRTX PE ratio history page last updated 4/15/2024
HRTX PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/12/2024
2.36-0.07-0.86NA
Q3 2023
11/14/2023
0.54-0.17-0.96NA
Q2 2023
8/14/2023
1.51-0.35-1.17NA
Q1 2023
5/11/2023
2.23-0.27-1.37NA
Q4 2022
3/23/2023
2.07-0.17-1.73NA
Q3 2022
11/8/2022
3.45-0.38-2.10NA
Q2 2022
8/9/2022
4.11-0.55-2.23NA
Q1 2022
5/9/2022
3.61-0.63-2.30NA
Q4 2021
2/28/2022
7.10-0.54-2.25NA
Q3 2021
11/3/2021
11.29-0.51-2.39NA
Q2 2021
8/9/2021
11.94-0.62-2.52NA
Q1 2021
5/10/2021
17.56-0.58-2.51NA
Q4 2020
2/24/2021
19.31-0.68-2.50NA
Q3 2020
11/5/2020
17.25-0.64-2.47NA
Q2 2020
8/5/2020
17.47-0.61-2.25NA
Q1 2020
5/6/2020
15.05-0.57-2.27NA
Q4 2019
3/2/2020
18.30-0.65-2.50NA
Q3 2019
11/12/2019
20.74-0.42-2.48NA
Q2 2019
8/5/2019
16.45-0.63-2.55NA
Q1 2019
5/9/2019
18.28-0.80-2.46NA
Q4 2018
2/22/2019
27.14-0.63-2.47NA
Q3 2018
11/7/2018
31.11-0.49-2.93NA
Q2 2018
8/8/2018
39.55-0.54-3.21NA
Q1 2018
5/10/2018
29.75-0.81-3.47NA
Q4 2017
2/27/2018
22.05-1.09-3.66NA
Q3 2017
11/6/2017
16.05-0.77-3.79NA
Q2 2017
8/9/2017
15.30-0.80-4.26NA
Q1 2017
5/10/2017
14.30-1.00-4.63NA
Q4 2016
2/23/2017
13.75-1.22-4.55NA
Q3 2016
11/8/2016
16.05-1.24-4.20NA
Q2 2016
8/8/2016
18.74-1.17-3.59NA
Q1 2016
5/5/2016
18.66-0.92-3.16NA
Q4 2015
2/19/2016
18.17-0.87-2.94NA
Q3 2015
11/6/2015
26.48-0.63-2.78NA
Q2 2015
8/7/2015
31.58-0.74-2.81NA
Q1 2015
5/8/2015
12.26-0.70-2.85NA
Q4 2014
2/19/2015
11.25-0.71NANA
Q3 2014
11/6/2014
7.39-0.66NANA
Q2 2014
8/4/2014
8.77-0.78NANA
HRTX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/12/2024
2.36-0.07-0.28NA
Q3 2023
11/14/2023
0.54-0.17-0.68NA
Q2 2023
8/14/2023
1.51-0.35-1.40NA
Q1 2023
5/11/2023
2.23-0.27-1.08NA
Q4 2022
3/23/2023
2.07-0.17-0.68NA
Q3 2022
11/8/2022
3.45-0.38-1.52NA
Q2 2022
8/9/2022
4.11-0.55-2.20NA
Q1 2022
5/9/2022
3.61-0.63-2.52NA
Q4 2021
2/28/2022
7.10-0.54-2.16NA
Q3 2021
11/3/2021
11.29-0.51-2.04NA
Q2 2021
8/9/2021
11.94-0.62-2.48NA
Q1 2021
5/10/2021
17.56-0.58-2.32NA
Q4 2020
2/24/2021
19.31-0.68-2.72NA
Q3 2020
11/5/2020
17.25-0.64-2.56NA
Q2 2020
8/5/2020
17.47-0.61-2.44NA
Q1 2020
5/6/2020
15.05-0.57-2.28NA
Q4 2019
3/2/2020
18.30-0.65-2.60NA
Q3 2019
11/12/2019
20.74-0.42-1.68NA
Q2 2019
8/5/2019
16.45-0.63-2.52NA
Q1 2019
5/9/2019
18.28-0.80-3.20NA
Q4 2018
2/22/2019
27.14-0.63-2.52NA
Q3 2018
11/7/2018
31.11-0.49-1.96NA
Q2 2018
8/8/2018
39.55-0.54-2.16NA
Q1 2018
5/10/2018
29.75-0.81-3.24NA
Q4 2017
2/27/2018
22.05-1.09-4.36NA
Q3 2017
11/6/2017
16.05-0.77-3.08NA
Q2 2017
8/9/2017
15.30-0.80-3.20NA
Q1 2017
5/10/2017
14.30-1.00-4.00NA
Q4 2016
2/23/2017
13.75-1.22-4.88NA
Q3 2016
11/8/2016
16.05-1.24-4.96NA
Q2 2016
8/8/2016
18.74-1.17-4.68NA
Q1 2016
5/5/2016
18.66-0.92-3.68NA
Q4 2015
2/19/2016
18.17-0.87-3.48NA
Q3 2015
11/6/2015
26.48-0.63-2.52NA
Q2 2015
8/7/2015
31.58-0.74-2.96NA
Q1 2015
5/8/2015
12.26-0.70-2.80NA
Q4 2014
2/19/2015
11.25-0.71-2.84NA
Q3 2014
11/6/2014
7.39-0.66-2.64NA
Q2 2014
8/4/2014
8.77-0.78-3.12NA
Quotes delayed 20 minutes

Email EnvelopeFree HRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Heron Therapeutics (HRTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

HSDT PE Ratio History
HSIC PE Ratio History
HSKA PE Ratio History
HSTO PE Ratio History
HTBX PE Ratio History
HTGM PE Ratio History
HUMA PE Ratio History
HZNP PE Ratio History
IART PE Ratio History
IBRX PE Ratio History
On this page we presented the HRTX PE Ratio History information for Heron Therapeutics' stock. The average HRTX PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average HRTX PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this HRTX PE ratio history result, against the recent PE: when this page was posted on 4/12/2024, the most recent closing price for HRTX had been 2.91, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on HRTX or any other given stock, valuation analysis for HRTX can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Heron Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for HRTX. Thanks for visiting, and the next time you need to research HRTX PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: CAFN Insider Buying, Funds Holding CAMP, GRC shares outstanding history.

 

HRTX PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.